SEARCH RESULTS FOR: (*Sandwhich Panel Machine*)(7286 results)
No Description
Guangzhou Berrcom Medical Device Co., Ltd
NC005
In Commercial Distribution
- 16947656115188 ()
- 06947656115181 ()
- HLA class II antibody identification panel IVD, kit, enzyme immunoassay (EIA)
No Description
Resolution Bioscience, Inc.
500029
Not in Commercial Distribution
- 00850059806005 ()
- Venous blood collection kit IVD
oncoReveal CDx Box 4 of 4. This box contains extra white and orange caps for reagents.
Pillar Biosciences, Inc.
HDA-LC-2001-48-4
In Commercial Distribution
- 00860001218251 ()
HDA-LC-2001-48-4
- Colorectal cancer genotyping IVD, kit, nucleic acid technique (NAT)
oncoReveal CDx Box 2 of 4. This box contains all of the indexing primers and indexing PCR master mix.
Pillar Biosciences, Inc.
HDA-LC-2001-48-2
In Commercial Distribution
- 00860001218237 ()
HDA-LC-2001-48-2
- Colorectal cancer genotyping IVD, kit, nucleic acid technique (NAT)
MasteRad MX-30 Radiographic System
Medicatech Usa, Inc.
MasteRad MX30
In Commercial Distribution
- 00860001404753 ()
MasteRad MX30
- Stationary basic diagnostic x-ray system, digital
oncoReveal CDx - Kit (Boxes 1 through 4)
Pillar Biosciences, Inc.
HDA-LC-2001-48
In Commercial Distribution
- 00860001218282 ()
HDA-LC-2001-4
- Colorectal cancer genotyping IVD, kit, nucleic acid technique (NAT)
The Pillar Variant Analysis Toolkit or PiVAT is an analytical software that comes on a preloaded workstation that is used to analyze sequencer data to generate applicable reports for the oncoReveal CDx
Pillar Biosciences, Inc.
SFW-2012 2.0
In Commercial Distribution
- 00860001218275 ()
SFW-2012
- Colorectal cancer genotyping IVD, kit, nucleic acid technique (NAT)
oncoReveal CDx Box 3 of 4. This box contains Purification Beads.
Pillar Biosciences, Inc.
HDA-LC-2001-48-3
In Commercial Distribution
- 00860001218244 ()
HDA-LC-2001-48-3
- Colorectal cancer genotyping IVD, kit, nucleic acid technique (NAT)
oncoReveal CDx Box 1 of 4. This box contains the Oligo Pool, Gene Specific Master Mix, Uracil-DNA Glycosylase (UDG), and Positive Control.
Pillar Biosciences, Inc.
HDA-LC-2001-48-1
In Commercial Distribution
- 00860001218220 ()
HDA-LC-2001-48-1
- Colorectal cancer genotyping IVD, kit, nucleic acid technique (NAT)
MI Cancer Seek is a next-generation sequencing (NGS) based in vitro diagnostic (IVD) device using total nucleic acid (TNA) isolated from formalin-fixed paraffin embedded (FFPE) tumor tissue specimens for the detection of single nucleotide variants (SNVs) and insertions and deletions (indels) in 228 genes, microsatellite instability (MSI) tumor
mutational burden (TMB) in patients with previously diagnosed solid tumors, and copy number amplification (CNA) in one gene in patients with breast cancer. MI Cancer Seek is intended as a companion diagnostic to identify patients who may benefit from treatment with the targeted therapies listed in the approved therapeutic product labeling. Additionally, MI Cancer Seek is intended to provide tumor mutational profiling to be used by qualified healthcare professionals in accordance with professional oncology guidelines for cancer patients with previously diagnosed solid malignant neoplasms. Genomic findings other than those listed as companion diagnostic indications are not prescriptive or conclusive for labeled use of any specific therapeutic product.
CARIS MPI, INC.
MCS000
In Commercial Distribution
- 00860008613325 ()
- Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)